CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.83
+0.58 (7.03%)
At close: Aug 1, 2025, 4:00 PM
8.64
-0.19 (-2.15%)
After-hours: Aug 1, 2025, 7:56 PM EDT

Accolade Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
771943--
Market Cap Growth
-44.61%-55.39%---
Enterprise Value
42-2733--
Last Close Price
8.832.347.63--
PS Ratio
8.261.986.06--
PB Ratio
2.220.495.87--
P/TBV Ratio
2.220.495.87--
EV/Sales Ratio
4.47-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.400.371.01--
Quick Ratio
9.3510.613.360.311.48
Current Ratio
9.7811.113.840.321.50
Return on Equity (ROE)
-93.42%-69.95%---
Return on Assets (ROA)
-56.19%-42.95%-69.12%-39.59%-
Return on Capital (ROIC)
-65.47%-48.91%-90.49%-44.40%-
Earnings Yield
-24.30%-84.35%-5.02%--
Buyback Yield / Dilution
-113.67%-203.34%-413.65%88.49%-
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q